Esketamine: Approved for MDD Monotherapy
Esketamine is first monotherapy for MDD with inadequate response to oral antidepressants, approved after a priority FDA review. Esketamine has been approved […]
Spravato Breakthrough Treatment
Spravato (esketamine therapy) is a promising treatment for those with treatment-resistant depression, offering rapid relief where traditional antidepressants may fail.
Everything You Need to Know About TMS
Transcranial Magnetic Stimulation (TMS) is an FDA-approved, non-invasive treatment for depression, especially for those who have not responded to traditional methods.
TMS for Teens: Everything You Need to Know
The FDA has approved the use of Transcranial Magnetic Stimulation (TMS) for treating Major Depressive Disorder (MDD) in adolescents aged 15 to […]